Tyrosinemia (TYRSN)
Author:
Publisher
Springer International Publishing
Link
https://link.springer.com/content/pdf/10.1007/978-3-319-66816-1_1802-1
Reference10 articles.
1. Bliksrud YT, Brodtkorb E, Andresen PA, van den Berg IET, Kvittingen EA (2005) Tyrosinaemia type I–de novo mutation in liver tissue suppressing an inborn splicing defect. J Mol Med 83:406–410. https://doi.org/10.1007/s00109-005-0648-2
2. Chinsky JM et al (2017) Diagnosis and treatment of tyrosinemia type I: a US and Canadian consensus group review and recommendations. Genet Med:19. https://doi.org/10.1038/gim.2017.101
3. Heylen E, Fau SG, Fau VM, Fau MS, Fau FJ, Nassogne MC (2012) Tyrosinemia type III detected via neonatal screening: management and outcome. Mol Genet Metab 107(3):605–607
4. Kvittingen EA, Halvorsen S, Jellum E (1983) Deficient fumarylacetoacetate fumarylhydrolase activity in lymphocytes and fibroblasts from patients with hereditary tyrosinemia. Pediatr Res 17:541–544. https://doi.org/10.1203/00006450-198307000-00005
5. Lindstedt S, Holme E, Lock EA, Hjalmarson O, Strandvik B (1992) Treatment of hereditary tyrosinaemia type I by inhibition of 4-hydroxyphenylpyruvate dioxygenase. Lancet 340:813–817. https://doi.org/10.1016/0140-6736(92)92685-9
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3